Tag: FDA

FDA: Class I recall of Hamilton-C6 Intensive Care Ventilator

Editor's Note The Food and Drug Administration (FDA) on August 29 identified the recall by Hamilton Medical AG of its Hamilton-C6 Intensive Care Ventilator as Class I, the most serious. The recall was initiated because of potential water ingress between the indicator board and the ventilator’s main board that may…

Read More

By: Judy Mathias
September 1, 2022
Share

FDA: Class I recall of Intera 3000 Hepatic Artery Infusion Pump

Editor's Note The Food and Drug Administration on August 29 identified the recall by Intera Oncology of its Intera 3000 Hepatic Artery Infusion Pump as Class I, the most serious. The company is recalling the pumps after receiving reports from clinicians that the pumps were delivering medication faster than expected.…

Read More

By: Judy Mathias
August 31, 2022
Share

FDA: Class I recall of Medtronic’s HeartWare HVAD system batteries

Editor's Note The Food and Drug Administration on August 25 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) system batteries as Class I, the most serious. Medtronic is recalling the batteries because they may experience electrical faults that cause them to unexpectedly fail. A similar recall…

Read More

By: Judy Mathias
August 29, 2022
Share

FDA: Hospira recalls another lot of Propofol

Editor's Note The Food and Drug Administration (FDA) on August 22 posted the Hospira Inc (a Pfizer company) recall of one lot of Propofol Injectable Emulsion (containing Benzyl alcohol), 100 mL single patient use glass fliptop vials, lot EA7470. The recall was initiated because of visible particulates observed in two…

Read More

By: Judy Mathias
August 23, 2022
Share

FDA: Class I recall of Medtronic Cobalt/Crome ICDs, CRT-Ds

Editor's Note The Food and Drug Administration (FDA) on August 19 identified the recall by Medtronic of its Cobalt XT, Cobalt, and Crome Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) as Class I, the most serious. The devices are being recalled because of reports of short circuit-protection…

Read More

By: Judy Mathias
August 22, 2022
Share

ISMP publishes new perioperative medication safety guidelines

Editor's Note The Institute for Safe Medication Practices (ISMP) on August 11 announced the publication of its first set of safe practice guidelines to support perioperative medication safety in hospitals, ambulatory surgery centers, and other procedural locations. The new guidelines: Address best practices related to labeling and storage of perioperative…

Read More

By: Judy Mathias
August 18, 2022
Share

FDA: Class I recall of BD Intraosseous Infusion System

Editor's Note The Food and Drug Administration (FDA) on August 11 classified the recall by Becton Dickinson (BD) of its Intraosseous Infusion System, which includes Intraosseous Needle Set Kits, Intraosseous Manual Driver Kits, and Intraosseous Powered Drivers, as Class I, the most serious. The recall was initiated for three separate…

Read More

By: Judy Mathias
August 11, 2022
Share

Move to stretch monkeypox vaccine supply via smaller doses

Editor's Note On Tuesday, August 9, US officials announced they will modify dosing instructions for the Jynneos monkeypox vaccine to stretch the supply, US News & World Report July 10 reports. Currently, there are almost 9,500 known cases in the US, predominantly among gay and bisexual men. According to the…

Read More

By: Lauren McCaffrey
August 10, 2022
Share

FDA: Class I recall of Haimen Shengbang Viral Transport Media Containers

Editor's Note The Food and Drug Administration (FDA) on August 9 identified the recall by Haimen Shengbang Laboratory Equipment Co Ltd of its Viral Transport Media Containers as Class I, the most serious. The recall was initiated because the products were distributed in the US without authorization, clearance, or approval…

Read More

By: Judy Mathias
August 10, 2022
Share

FDA: Class I recall of North American Diagnostics’ COVID-19 test

Editor's Note The Food and Drug Administration (FDA) on August 1 identified the recall by North American Diagnostics of its Oral Rapid SARS-CoV-2 Rapid Antigen Test Kits as Class I, the most serious. These tests are being recalled because they were distributed in the US without authorization, clearance, or approval…

Read More

By: Judy Mathias
August 9, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat